Selected Approaches to Disrupting Protein-Protein Interactions within the MAPK/RAS Pathway.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Apr 2023
Historique:
received: 24 03 2023
revised: 11 04 2023
accepted: 12 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Within the MAPK/RAS pathway, there exists a plethora of protein-protein interactions (PPIs). For many years, scientists have focused efforts on drugging KRAS and its effectors in hopes to provide much needed therapies for patients with

Identifiants

pubmed: 37108538
pii: ijms24087373
doi: 10.3390/ijms24087373
pmc: PMC10139024
pii:
doi:

Substances chimiques

Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2012 Feb 23;366(8):707-14
pubmed: 22356324
J Med Chem. 2015 May 28;58(10):4165-79
pubmed: 25965804
Nature. 2013 Nov 28;503(7477):548-51
pubmed: 24256730
Protein Sci. 1998 Sep;7(9):1884-97
pubmed: 9761470
J Med Chem. 2022 Mar 10;65(5):3923-3942
pubmed: 35230841
J Med Chem. 2020 Jul 9;63(13):6679-6693
pubmed: 32250617
J Med Chem. 2021 May 27;64(10):6569-6580
pubmed: 33719426
Top Curr Chem. 2012;317:145-79
pubmed: 22006238
PLoS One. 2016 Feb 17;11(2):e0149439
pubmed: 26886014
J Med Chem. 2022 Feb 10;65(3):1898-1914
pubmed: 35104933
Nature. 2007 Dec 13;450(7172):1001-9
pubmed: 18075579
Bioorg Chem. 2021 Dec;117:105447
pubmed: 34715575
Cell Death Dis. 2018 Feb 13;9(2):216
pubmed: 29440631
N Engl J Med. 2019 Aug 15;381(7):626-636
pubmed: 31166680
Signal Transduct Target Ther. 2020 Sep 23;5(1):213
pubmed: 32968059
Nat Rev Drug Discov. 2022 Mar;21(3):181-200
pubmed: 35042991
Drug Discov Today Technol. 2004 Dec;1(4):337-41
pubmed: 24981612
Nat Commun. 2018 Aug 9;9(1):3169
pubmed: 30093669
J Med Chem. 2017 Nov 22;60(22):9400-9406
pubmed: 28929751
J Clin Oncol. 2021 Feb 1;39(4):273-284
pubmed: 33503393
Biochem J. 2021 Jul 30;478(14):2793-2809
pubmed: 34232285
Nat Commun. 2020 Sep 1;11(1):4370
pubmed: 32873792
Nat Rev Drug Discov. 2004 Apr;3(4):301-17
pubmed: 15060526
Curr Opin Chem Biol. 2009 Jun;13(3):284-90
pubmed: 19553156
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775
pubmed: 27791178
J Med Chem. 2022 Feb 24;65(4):3123-3133
pubmed: 34889605
J Med Chem. 2014 Jun 26;57(12):5435-48
pubmed: 24884780
Nature. 2013 May 30;497(7451):638-42
pubmed: 23698361
N Engl J Med. 2021 Jun 24;384(25):2371-2381
pubmed: 34096690
J Biol Chem. 2018 Aug 31;293(35):13696-13706
pubmed: 29970615
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15823-15829
pubmed: 31332011
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2545-2550
pubmed: 30683716
Mol Cancer Ther. 2020 Feb;19(2):460-467
pubmed: 31645440
Cancer Discov. 2022 Apr 1;12(4):924-937
pubmed: 35046095
J Med Chem. 2015 Feb 26;58(4):1818-31
pubmed: 25611072
Mol Cell. 2020 Jul 2;79(1):191-198.e3
pubmed: 32619469
Curr Opin Chem Biol. 2018 Jun;44:75-86
pubmed: 29908451
J Mol Biol. 1999 Feb 5;285(5):2177-98
pubmed: 9925793
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5299-304
pubmed: 22431598
Nature. 2011 Nov 23;480(7377):387-90
pubmed: 22113612
Drug Discov Today. 2009 Feb;14(3-4):155-61
pubmed: 19041415
J Mol Recognit. 2002 Nov-Dec;15(6):405-22
pubmed: 12501160
Cancer Cell. 2015 Sep 14;28(3):384-98
pubmed: 26343583
J Med Chem. 2021 May 27;64(10):6566-6568
pubmed: 33961431
ACS Cent Sci. 2020 Oct 28;6(10):1753-1761
pubmed: 33145412
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2551-2560
pubmed: 30683722
BMC Cancer. 2018 Dec 29;18(1):1299
pubmed: 30594165
Trends Pharmacol Sci. 2013 Jul;34(7):393-400
pubmed: 23725674
J Hematol Oncol. 2020 Mar 30;13(1):26
pubmed: 32228680
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
BMC Cancer. 2018 Nov 1;18(1):1056
pubmed: 30382908
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
Cell. 1992 Aug 7;70(3):431-42
pubmed: 1322798
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
Blood Cancer J. 2022 Apr 14;12(4):64
pubmed: 35422065
ACS Chem Biol. 2017 Jul 21;12(7):1956-1962
pubmed: 28530791
Cell. 2011 Mar 18;144(6):986-98
pubmed: 21414488
Oncogene. 2018 Oct;37(43):5719-5734
pubmed: 29930381
IUBMB Life. 2010 Oct;62(10):724-31
pubmed: 20979208
Curr Opin Chem Biol. 2011 Aug;15(4):475-81
pubmed: 21684802
ACS Med Chem Lett. 2013 Feb 07;4(3):358-62
pubmed: 24900673
Mol Cell. 2016 Dec 1;64(5):875-887
pubmed: 27889448
Protein Sci. 2009 Mar;18(3):481-93
pubmed: 19241367
Angew Chem Int Ed Engl. 2012 Jun 18;51(25):6140-3
pubmed: 22566140
Curr Opin Chem Biol. 2021 Jun;62:109-118
pubmed: 33848766
J Mol Biol. 1997 Apr 11;267(4):933-52
pubmed: 9135122
Chem Soc Rev. 2015 Nov 21;44(22):8238-59
pubmed: 26248294
Br J Cancer. 2018 Jan;118(1):3-8
pubmed: 29235562
ACS Cent Sci. 2020 Aug 26;6(8):1367-1375
pubmed: 32875077
Oncogene. 2018 Feb 8;37(6):821-832
pubmed: 29059158
J Hematol Oncol. 2022 Oct 25;15(1):152
pubmed: 36284306
Eur J Med Chem. 2022 Feb 15;230:114088
pubmed: 35007863
Mol Inform. 2014 Jun;33(6-7):414-437
pubmed: 25254076
Chem Biol. 1995 Jan;2(1):53-60
pubmed: 9383403
Nat Biotechnol. 2007 Jan;25(1):71-5
pubmed: 17211405
Nat Struct Mol Biol. 2023 Feb;30(2):216-225
pubmed: 36690744
Nature. 2020 Apr;580(7803):402-408
pubmed: 32296183
Cell. 2016 Apr 21;165(3):643-55
pubmed: 27104980
J Med Chem. 2022 Jul 28;65(14):9678-9690
pubmed: 35833726
J Med Chem. 2020 Jan 9;63(1):52-65
pubmed: 31820981
J Exp Clin Cancer Res. 2022 Jan 19;41(1):27
pubmed: 35045886
Cell. 2010 Jan 22;140(2):209-21
pubmed: 20141835
Cancer Cell. 2016 Sep 12;30(3):485-498
pubmed: 27523909
J Med Chem. 2021 Apr 8;64(7):3940-3955
pubmed: 33780623
ACS Comb Sci. 2016 Jan 11;18(1):75-85
pubmed: 26645887
Chem Sci. 2017 Jul 1;8(7):4756-4763
pubmed: 28959398
Angew Chem Int Ed Engl. 2017 Feb 20;56(9):2423-2428
pubmed: 28106325
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6
pubmed: 18287029
Lancet Oncol. 2018 May;19(5):603-615
pubmed: 29573941
Nature. 2010 Mar 18;464(7287):431-5
pubmed: 20130576
Angew Chem Int Ed Engl. 2019 Nov 4;58(45):16314-16319
pubmed: 31557383
Nat Med. 2022 Oct;28(10):2171-2182
pubmed: 36216931
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
Mol Pharm. 2017 May 1;14(5):1548-1557
pubmed: 28060514
J Med Chem. 2018 Mar 22;61(6):2604-2610
pubmed: 29510040
Nat Rev Clin Oncol. 2022 Oct;19(10):637-655
pubmed: 36028717
Cancer Discov. 2021 Jan;11(1):142-157
pubmed: 32816843
Chem Rev. 2014 May 14;114(9):4695-748
pubmed: 24735440
Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81
pubmed: 12800163
Cell Mol Biol Lett. 2009;14(1):1-22
pubmed: 18839074
Nat Rev Drug Discov. 2020 Aug;19(8):533-552
pubmed: 32528145
Chemistry. 2017 May 2;23(25):6083-6093
pubmed: 27809361
Chem Rev. 2008 Apr;108(4):1225-44
pubmed: 18355092
J Clin Oncol. 2022 Aug 10;40(23):2530-2538
pubmed: 35167329
Nature. 2014 Apr 3;508(7494):118-22
pubmed: 24670642
Nat Commun. 2020 Jun 26;11(1):3233
pubmed: 32591521
J Mol Biol. 1998 Jul 3;280(1):1-9
pubmed: 9653027
Cancer Res. 1989 Sep 1;49(17):4682-9
pubmed: 2547513
J Biol Chem. 1995 Aug 4;270(31):18212-5
pubmed: 7629138
Expert Rev Mol Med. 2012 Jul 26;14:e16
pubmed: 22831787
N Engl J Med. 2012 Nov;367(18):1694-703
pubmed: 23020132
Nat Rev Cancer. 2017 Nov;17(11):676-691
pubmed: 28984291
Nature. 1998 Jul 23;394(6691):337-43
pubmed: 9690470
Nat Rev Drug Discov. 2016 Aug;15(8):533-50
pubmed: 27050677
Cell. 2014 Apr 10;157(2):459-471
pubmed: 24725411
Expert Opin Ther Targets. 2007 Dec;11(12):1587-609
pubmed: 18020980
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188445
pubmed: 33035641
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494

Auteurs

Stephen J Harwood (SJ)

Mirati Therapeutics, 3545 Cray Court, San Diego, CA 92121, USA.

Christopher R Smith (CR)

Mirati Therapeutics, 3545 Cray Court, San Diego, CA 92121, USA.

J David Lawson (JD)

Mirati Therapeutics, 3545 Cray Court, San Diego, CA 92121, USA.

John M Ketcham (JM)

Mirati Therapeutics, 3545 Cray Court, San Diego, CA 92121, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH